SCHEMBL25003794

SCHEMBL25003794

CCCOc1ccc(-c2nccc(C(=O)NN)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 1/20 0.49
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ ACACB O00763 2/20 0.46
▸ XDH P47989 1/20 0.46
▸ CHRNB2 P17787 5/20 0.45
▸ CHRNA4 P43681 5/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ CHRNB4 P30926 4/20 0.45
▸ CHRNA3 P32297 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ S1PR1 P21453 1/20 0.44
▸ S1PR3 Q99500 1/20 0.44
▸ ACACA Q13085 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003134 0.95 NPC1 (0.51) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL25003126 0.90 ALDH1A1 (0.51) PLK1KMT2AMEN1ACACBXDH
SCHEMBL25002912 0.86 PLA2G2A (0.48) PLK1KMT2AMEN1ACACBXDH
SCHEMBL25003826 0.85 CA1 (0.54) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL25003142 0.82 ALDH1A1 (0.53) KMT2AMEN1ACACBXDHRAB9A
SCHEMBL25002892 0.81 NPC1 (0.52) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL25003153 0.80 KMT2A (0.48) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL25003806 0.80 ALDH1A1 (0.48) PLK1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL25003131 0.78 MAP4K4 (0.55) KMT2AMEN1XDHRAB9AKDM4E
SCHEMBL6538458 0.78 PLK1 (0.69) PLK1KMT2AMEN1XDHCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback